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PLASTICS IN PHARMACY AND MEDICINE*
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Western Cape, Bellville, CP
Modern packaging and manufacturing trends are such
that the medical and paramedical sciences are almost
daily using plastic materials in the form of tubing, syrin-
ges, containers, transfusion kits, etc. The field of plastic
materials is an enormous one, and the purpose of this
article is to point out some of the disadvantages or
hazards of plastic materials as related to para-medicine,
while acknowledging in general the undoubted usefulness
of these polymers, and accepting their continued intro-
duction into medicine as inevitable.
Autian' has given an excellent review of plastics in
pharmaceutical practice and in related fields, and although
this review appeared less than a decade ago, his work
has given ·mpetus to much research on plastic-drug inter-
actions. The use of plastics as packaging materials has
been reviewed more recently by Sacharow",3 Hughes;
and Polack: It has been shown that plasticizers in plastic
films may actively support the growth of fungi, while poly-
ethylene and cellulose acetate are reported to be permeable
to bacteria."
TYPES OF PLASTIC
The types of plastics most likely to be encountered in
para-medicine are polyethylene (polythene), polypropylene,
polycarbonate, polyvinylchIoride (pVC) and nylon. Poly-
styrene is used for the packaging of tablets, but is easily
cracked because of its low impact strength. Killingback6
has outlined many of the advantages of polystyrene, but
its high water vapour transmission rate, as also its high
oxygen permeability, makes it unsuitable for liquids, or
for solids requiring protection from moisture. Killingback6
points out that, in the USA alone, some 4500 million
plastic containers are used annually, and with the intro-
duction of PVC medicine bottles into use in Great Britain
this year, glass containers may become redundant, which
in my opinion would be a pity, since glass can be closely
standardized in its properties, whereas a plastic (e.g. poly-
thene) may vary from batch to batch even from the same
manufacturer. This is largely due to the various additives
added to the polymer during manufacture.
PROPERTIES OF PLASTICS
Plastic containers are lighter, cheaper and less fragile
than glass containers. Certain plastics are deformable,
and thus are useful for 'squeeze-packs' (nasal sprays,
wash bottles, etc.) but it must be remembered that air is
sucked back into such containers on release, and this
forms a potential source of contamination by aerial flora.
Rigidity of plastic usually increases with increase in den-
sity, and thus one speaks, for example, of low-density or
high-density polythene. The latter is stiffer, less permeable
to gases and vapours, and more opaque than the former.
Opacity is a disadvantage not shared by glass, where the
container contents may quickly be scanned for precipi-
tation or microbial growth. PVC is transparent, as also
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are film packagings, but denser (container) plastics are
usually opaque, although some are translucent. It should
be remembered that plastics, like clear glass, do not
afford protection from actinic light, which causes photo-
chemical decomposition. Many drugs these days (steroids,
tranquillizers, vitamins) require protection from light, and
coloured glass or specially formulated plastics filter out
the ultraviolet rays which cause decomposition. However,
it must be stressed to dispensing doctors who keep win-
chester (stock) bottles of ethicals supplied in coloured
glass containers that dispensing of smaller volumes of
such solutions (or tablets) into containers of clear glass,
or of plastic, will result in rapid decomposition of the
active ingredient(s).
Glass is chemically very unreactive, and can thus be
used to store a wide range of substances or solutions.
Alkaline solutions require to be stored in lead-free glass,
while soda glass can impart sufficient alkalinity to stored
solutions so as to precipitate salts of weak bases, such
as alkaloidal salts. Good quality glass (ampoules) is vir-
tually unreactive.. Plastics, on the other hand, are soluble
in certain organic solvents (e.g. benzene, furan), but this
is not of any great significance in medical practice. How-
ever, the effect of certain medicaments will be mentioned
later. What is of greater significance is the fact that plas-
tics frequently contain additives such as plasticizers. ther-
mal stabilizers, fillers, anti-oxidants and mould lubricants.
Leaching out of such constituents will later be shown
to cause toxic reactions in patients (tubing), or untoward
reactions in medicines.
Further unwanted properties of plastic not possessed by
glass are transmission and sorption. Transmission refers
to vapours, flavours, gases (especially oxygen) and mois-
ture vapour. This transmission may be inward or out-
ward, and such permeability is obviously undesirable.
Polystyrene and PVC have the highest water vapour
transmission rates, while the former, and the lower den-
sity polymers, allow the highest vapour transmission.
However, there have been good reports of pharmaceuticals
packed both in PVC and in high-density polythene. The
latter, nylon, and high-density polypropylene are all auto-
clavable, but volatile substances, especially phenolic pre-
servatives, are lost under such conditions, and this leads
us to sorption.
Sorption applies to both surface adsorption, and pene-
tration by absorption. When the absorbed substance
reaches the outer wall it is lost to the atmosphere. If
adsorbed onto the container wall its concentration obvi-
ously decreases in the bulk solution, and atropine-borate
eyedrops stored in polyethylene bottles have been shown
to have lost most of the active ingredient in this manner.
PARAMEDICAL DISADVANTAGES OF PLASTIC
Although certain pharmaceuticals have been satisfactorily
stored in plastic containers, there have also been several
adverse reports. The preservative benzyl alcohol (2%)
is capable of dissolving polystyrene syringes,7 and the
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latter type has also been dissolved by paraldehyde injec-
tion within 5 hours. Dimercaprol injection causes etching
and clouding on polystyrene barrels, but does not affect
polythene or nylon barrels. However, nylon barrels, being
polyamide, have been found to be very reactive," and
nylon syringes stored for one week at 50°C in various
preservative solutions sorbed from 40 0 0 to 80 0 0 of the 10
phenolic or acidic (organic) preservatives used.
My interest lies in preservative inactivation,"" since
most modern pharmaceuticals are factory-produced, and
to many such products, particularly liquid preparations,
a preservative is added, because, unlike extemporaneously
dispensed medicines, these products may stand on the
shelf for months before use. Any material causing destruc-
tion of the preservative, or diminution below its inhibitory
concentration, must obviously be rejected. Adjuvants in
the formulation of a medicine may themselves cause
preservative inactivation, but this is a pharmaceutical
rather than a medical problem. However, inactivation by
the container may well affect the dispensing doctor, and
sorption of preservatives into plastic containers has been
studied by several workers."'"'''''· I have studied South
African-made PVC and polythene (medium density)
bottles,""s and found the former resistant to most com-
monly used preservatives at normally used concentration
(ca. 0'1 %). The polythene bottles were satisfactory for
long-chain molecules such as benzalkonium (Zephiran)
or chlorhexidine (Hibitane), as also for organic acids
(benzoic), but substituted phenolics, such as chlorocresol,
O-phenylphenol and dichlorophenol decreased (respec-
tively) by about 25~{" 80% and 90% of the initial concen-
tration (0'05~{, w/ v) after only 4 weeks' storage at 25°C.
At present a study is being undertaken on a series of
substituted phenols, creso!s and xylenols solubilized in
Tween 80 and stored in polythene.
Autians has listed 16 parenteral products which dis-
coloured polythene hypodermics (after accelerated storage
at 50°C for one week) and these include such well-known
medicinals as adrenaline hydrochloride, Phenergan, Seco-
nal sodium. Serpasil and terramycin. Steroids are adsorbed
to polythene tubes, and such adsorption is normal from
dilute solutions, whereas from more concentrated solutions
dimerization of certain molecules may occur, and the plas-
tic may actually be attacked and dissolved at certain points.
Two interesting articles19". on ophthalmic preservative loss
from polythene on autoclaving have appeared, and although
the use of gamma-irradiation presterilization of containers
will largely obviate the accelerated loss on heating, as
will the excellent innovation of unit-dosage (where no
preservative will be required), the interaction at room
temperature between plastic ophthalmic containers and
their preservative could still be a pitfall for the unwary.
In contrast to sorption problems, where loss of con-
stituent is observed, leaching from plastic into the solu-
tion introduces unwanted and potentially toxic products.
PVC has been shown to release both stabilizers and
plasticizers to solutions of dextrose and of mline, and one
such stabilizer, although showing no haemolytic effects
(as had been reported previously for PVC tubing extracts),
caused a cardiotoxic response to an animal heart when
released from the (pVC) tubing to the perfusion fluid.
A colourant used in plastic-hubbed hypodermic needles
released into saline a constituent lethal to mice. Steriliza-
5
tion may cause further problems. Ethylene oxide should
not be used to sterilize PVC because of the danger of
formation of ethylene chlorhydrin. However, polypropy-
lene transfusion kits have passed rigid Swedish tests, and
have the decided advantage over glass of not shedding
anywhere near the amount of particu!ate matter te-
solutions.
Legislation
Finally, what protective legislation regarding the safe
use of plastics has been formulated? Simpson" has re-
viewed this well, and it is encouraging to note that the
British Plastics Federation has already applied a toxicity
rating to some 500 plastic ingredients. Pyrogenic and
toxicity tests are performed, as well as carcinogenicity
testing for implants. In this connection a most interesting
article by Grasso" on carcinogenicity testing is worthy
of mention. Several plastics were effective in inducing
tumours when implanted subcutaneously as 2-cm' discs
in rats. (Noble metals and glass were equally potent
sarcoma inducers.) What was interesting was that per-
foration of the plastic implant with a sewing needle con-
siderab.y reduced tumour formation, while the same
material in powdered form (even though this produces a
larger surface area) produced no tumours at all. Thus
tumour formation seemed to be of physical rather than
chemical origin.
Plastics are here to stay. Seeing that the polymers
differ tremendously in chemical composition it will not
be easy to predict untoward reactions, and consequently
an awareness of potential problems will not be amiss.
SUMMARY
The use of plastic materials in the paramedical disciplines is
increasing. Some of th~ properties of the mor~ commonly used
plastics have been described, as also the disadvantages with
respect to certain intrinsic properties of plastics not normally
encountered in glass, namely. leaching, sorption and trans-
mission. Although transmission of oxygen. water vapour,
flavours, etc.. may rightly be regarded as a problem for pharma-
ceutical manufacturers, the effects of leaching and sorption
apply equally to both pharmacy and medicine, and at a time
when untoward effects from drug interaction are increasingly
being reported, the potential hazards of plastic materials must
b~ mentioned.
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